EHANG HOLDINGS LTD-SPS ADR (EH)

US26853E1029 - ADR

18.68  +0.44 (+2.41%)

After market: 18.65 -0.03 (-0.16%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to EH. EH was compared to 63 industry peers in the Aerospace & Defense industry. The financial health of EH is average, but there are quite some concerns on its profitability. EH is valued quite expensive, but it does show an excellent growth.



1

1. Profitability

1.1 Basic Checks

In the past year EH has reported negative net income.
In the past 5 years EH always reported negative net income.
EH had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

EH's Return On Assets of -50.40% is on the low side compared to the rest of the industry. EH is outperformed by 76.19% of its industry peers.
EH's Return On Equity of -141.12% is on the low side compared to the rest of the industry. EH is outperformed by 73.02% of its industry peers.
Industry RankSector Rank
ROA -50.4%
ROE -141.12%
ROIC N/A
ROA(3y)-56.95%
ROA(5y)-41.16%
ROE(3y)-166.52%
ROE(5y)-111.12%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

EH's Gross Margin of 64.13% is amongst the best of the industry. EH outperforms 98.41% of its industry peers.
In the last couple of years the Gross Margin of EH has grown nicely.
EH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.84%
GM growth 5Y4.82%

5

2. Health

2.1 Basic Checks

EH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EH has been increased compared to 1 year ago.
The number of shares outstanding for EH has been increased compared to 5 years ago.
The debt/assets ratio for EH has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 7.97 indicates that EH is not in any danger for bankruptcy at the moment.
EH has a Altman-Z score of 7.97. This is amongst the best in the industry. EH outperforms 92.06% of its industry peers.
EH has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
EH's Debt to Equity ratio of 0.37 is fine compared to the rest of the industry. EH outperforms 61.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 7.97
ROIC/WACCN/A
WACC7.49%

2.3 Liquidity

A Current Ratio of 1.81 indicates that EH should not have too much problems paying its short term obligations.
With a Current ratio value of 1.81, EH perfoms like the industry average, outperforming 50.79% of the companies in the same industry.
A Quick Ratio of 1.57 indicates that EH should not have too much problems paying its short term obligations.
EH's Quick ratio of 1.57 is fine compared to the rest of the industry. EH outperforms 68.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.57

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.72% over the past year.
The Revenue has grown by 164.96% in the past year. This is a very strong growth!
The Revenue has been growing by 12.04% on average over the past years. This is quite good.
EPS 1Y (TTM)12.72%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q71.43%
Revenue 1Y (TTM)164.96%
Revenue growth 3Y-13.29%
Revenue growth 5Y12.04%
Revenue growth Q2Q260.99%

3.2 Future

Based on estimates for the next years, EH will show a very strong growth in Earnings Per Share. The EPS will grow by 43.77% on average per year.
Based on estimates for the next years, EH will show a very strong growth in Revenue. The Revenue will grow by 112.29% on average per year.
EPS Next Y82.49%
EPS Next 2Y63.13%
EPS Next 3Y43.77%
EPS Next 5YN/A
Revenue Next Year248.75%
Revenue Next 2Y157.31%
Revenue Next 3Y112.29%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

EH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year EH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

EH's earnings are expected to grow with 43.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y63.13%
EPS Next 3Y43.77%

0

5. Dividend

5.1 Amount

EH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EHANG HOLDINGS LTD-SPS ADR

NASDAQ:EH (4/29/2024, 7:00:01 PM)

After market: 18.65 -0.03 (-0.16%)

18.68

+0.44 (+2.41%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.19B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.4%
ROE -141.12%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 64.13%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.81
Quick Ratio 1.57
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)12.72%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y82.49%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)164.96%
Revenue growth 3Y-13.29%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y